In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefoxitin Sodium Drug Master File in Korea (Cefoxitin Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefoxitin Sodium. The MFDS reviews the Cefoxitin Sodium KDMF as part of the drug registration process and uses the information provided in the Cefoxitin Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefoxitin Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefoxitin Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefoxitin Sodium suppliers with KDMF on PharmaCompass.